Yonghe Medical Group Co., Ltd. (HKG:2279)
1.970
-0.020 (-1.01%)
At close: Feb 13, 2026
Yonghe Medical Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 555.89 | 487.84 | 603.22 | 565.09 | 1,566 | 292.86 |
Short-Term Investments | 44.8 | 53 | 69.92 | 477.3 | 52.81 | 43.61 |
Cash & Short-Term Investments | 600.69 | 540.84 | 673.14 | 1,042 | 1,619 | 336.46 |
Cash Growth | -0.36% | -19.65% | -35.42% | -35.62% | 381.18% | 183.58% |
Accounts Receivable | 5.76 | 4.63 | 10.27 | 7.06 | 13.35 | 10.33 |
Other Receivables | 0.68 | 2.02 | 4.16 | 1.93 | 3.98 | 7.95 |
Receivables | 6.43 | 6.65 | 14.43 | 8.99 | 17.34 | 18.28 |
Inventory | 26.21 | 43.59 | 79.66 | 94.97 | 61.38 | 31.44 |
Prepaid Expenses | 19.08 | 21.5 | 23.85 | 31.2 | 36.73 | 45.11 |
Restricted Cash | 0.32 | 5.15 | - | - | - | - |
Other Current Assets | 10.83 | 12.08 | 18.26 | 11.93 | 14.19 | 6.32 |
Total Current Assets | 663.57 | 629.82 | 809.33 | 1,189 | 1,749 | 437.61 |
Property, Plant & Equipment | 793.96 | 936.54 | 1,490 | 1,632 | 1,375 | 1,120 |
Goodwill | - | - | 10.33 | 25.16 | 25.16 | - |
Other Intangible Assets | 24.51 | 25.85 | 18.05 | 14.52 | 16.1 | 3.55 |
Long-Term Deferred Tax Assets | 131.47 | 133.06 | 107.63 | 60.42 | 32.54 | 29.01 |
Long-Term Deferred Charges | - | - | 6.79 | - | - | - |
Other Long-Term Assets | 0.96 | 0.92 | 2.11 | 9.26 | 1.51 | 4.09 |
Total Assets | 1,614 | 1,726 | 2,445 | 2,930 | 3,199 | 1,594 |
Accounts Payable | 47.93 | 43.88 | 79.42 | 43.97 | 36.06 | 44.68 |
Accrued Expenses | 67.41 | 81.81 | 100.79 | 82.43 | 146.56 | 78.85 |
Short-Term Debt | 5 | 50.05 | 152.82 | - | 99.53 | 25.9 |
Current Portion of Leases | 129.29 | 150.55 | 170.04 | 190.55 | 185.06 | 147.05 |
Current Income Taxes Payable | 11.06 | 5.64 | 6.81 | 8.86 | 63.22 | 73.62 |
Current Unearned Revenue | 205.54 | 190.05 | 182.36 | 154.98 | 189.52 | 120.42 |
Other Current Liabilities | 19.44 | 23.73 | 30.66 | 17.72 | 17.74 | 14.68 |
Total Current Liabilities | 485.67 | 545.71 | 722.9 | 498.51 | 737.68 | 505.2 |
Long-Term Leases | 386.69 | 466.53 | 772.69 | 845.05 | 762.3 | 682.88 |
Long-Term Deferred Tax Liabilities | 0.46 | 0.13 | 6.72 | 1.5 | 0.98 | 0.22 |
Total Liabilities | 872.83 | 1,012 | 1,502 | 1,345 | 1,501 | 1,188 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - |
Additional Paid-In Capital | 1,330 | 1,330 | 1,332 | 1,332 | 1,240 | - |
Retained Earnings | -568.27 | -596.18 | -369.84 | 176.56 | 302.48 | 252.09 |
Treasury Stock | -0.19 | -0.15 | - | - | - | - |
Comprehensive Income & Other | -19.78 | -19.85 | -19.9 | 76.46 | 155.45 | 153.97 |
Total Common Equity | 742.23 | 714.34 | 942.56 | 1,585 | 1,698 | 406.06 |
Minority Interest | -0.59 | -0.53 | -0.31 | - | - | - |
Shareholders' Equity | 741.64 | 713.81 | 942.25 | 1,585 | 1,698 | 406.06 |
Total Liabilities & Equity | 1,614 | 1,726 | 2,445 | 2,930 | 3,199 | 1,594 |
Total Debt | 520.99 | 667.13 | 1,096 | 1,036 | 1,047 | 855.83 |
Net Cash (Debt) | 79.7 | -126.29 | -422.42 | 6.79 | 572.12 | -519.37 |
Net Cash Growth | - | - | - | -98.81% | - | - |
Net Cash Per Share | 0.16 | -0.25 | -0.83 | 0.01 | 1.33 | -1.24 |
Filing Date Shares Outstanding | 525.22 | 500.26 | 501.97 | 516.67 | 519.96 | 367.87 |
Total Common Shares Outstanding | 525.22 | 500.26 | 501.97 | 516.67 | 519.96 | 367.87 |
Working Capital | 177.9 | 84.1 | 86.43 | 690.97 | 1,011 | -67.59 |
Book Value Per Share | 1.41 | 1.43 | 1.88 | 3.07 | 3.27 | 1.10 |
Tangible Book Value | 717.72 | 688.49 | 914.18 | 1,546 | 1,657 | 402.51 |
Tangible Book Value Per Share | 1.37 | 1.38 | 1.82 | 2.99 | 3.19 | 1.09 |
Machinery | 148.06 | 930.34 | 1,030 | 128.06 | 99.26 | 73.94 |
Leasehold Improvements | 716.98 | - | - | 775.12 | 527.61 | 347.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.